SRE and Cofepris hold Health and Access to Medicines Seminar-EU Global Gateway | Federal Commission for the Protection against Health Risks | Government

  • During the meeting, representatives of the biopharmaceutical sector of the European system and the Mexican pharmaceutical industry exchanged good practices to guarantee the resilience of health systems and move towards health self-sufficiency in the Latin American region.

The Secretariats of Foreign Affairs and Health, through the Federal Commission for the Protection against Health Risks (Cofepris), as well as the embassies of Belgium and Denmark and the Delegation of the European Union (EU) in Mexico, organized the Health Seminar and Access to Medicines-EU Global Gateway, which takes place on June 20 and 21 at the Matías Romero Institute (IMR).

The meeting aims to promote a rapprochement between the biopharmaceutical sector of the European system with the Mexican pharmaceutical industry, with the purpose of exchanging good practices to guarantee the resilience of health systems, the construction of international alliances for the supply of vaccines and availability equitable distribution of medicines, as well as moving towards health self-sufficiency in the Latin American region.

During his intervention at the high-level panel, the Undersecretary for Multilateral Affairs and Human Rights of the SRE, Joel Hernández García, highlighted the efforts made by the Federal Government to strengthen the pharmaceutical sector, through interregional integration mechanisms between Latin America. and the EU to confront health crises, based on the lessons learned from the pandemic. These strategies will allow a medium and long-term increase in the manufacturing capacities of local and general-use medical supplies, through access to innovative products.

For his part, the federal commissioner for Protection against Health Risks, Alejandro Svarch Pérez, recognized the importance of international cooperation between governments and industry to enhance the population’s access to health products, through regulatory channels that guarantee efficient health services. and innovative quality, safe and effective pharmaceutical specialties. He also pointed out that self-sufficiency in health and the professionalization of personnel, through the Regional Health Regulation School (ERRS), are fundamental pillars to achieve the universalization of health in our country.

Likewise, the ambassador of the Kingdom of Belgium in Mexico, Johan Verkammen, urged to intensify the alliance between Mexico and the EU in the health sector. Belgium, which holds the presidency of the EU Council in the first half of 2024, is one of the world’s leading exporters of pharmaceutical products, particularly vaccines. Recently, cooperation between Mexico and the EU has been promoted through the Global Gateway Investment Strategy, which identified as one of its emblematic projects the creation of an EU-LAC Partnership on vaccine production and resilience of health systems, which Cofepris is a key actor. This seminar constitutes a concrete action in the construction of this strategic partnership.

Likewise, the Danish ambassador to Mexico, Kim Højlund Christensen, reaffirmed that Mexico and Denmark maintain a solid collaboration in the health sector, which constitutes an essential part of the bilateral relationship. Denmark has a strong health system due to innovation and equitable access to medicines, so exchanges between the countries are mutually beneficial. Likewise, Danish companies in the health sector contribute to the construction of valuable solutions, in addition to generating employment and growth both in Mexico and in their country.

Ambassador Højlund also highlighted the importance of ensuring the resilience of health systems and recognized the successful technical cooperation between Cofepris and the Danish authorities. He stated that cooperation with Denmark will continue to strengthen, predicting good results through Global Gateway initiatives.

Representatives of the Mexican, Belgian and Danish pharmaceutical industry participated in the event, as well as officials from more than 20 countries, from the diplomatic corps accredited in our country.

The Government of Mexico seeks to consolidate biotechnological systems, promoting international partnerships and attracting investments to strengthen the technical and research capabilities of our country; Therefore, public-private collaboration is essential to expand opportunities for development and expansion of supply chains in the region, allowing access to more accessible biotechnological medicines that benefit the population.


For Latest Updates Follow us on Google News


NEXT Eleven applications for each position offered in Medicine and nearly eight in Veterinary Medicine